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Can phlebectomy be deferred in the treatment of
varicose veins?
Daniel L. Monahan, MD, Roseville, Calif
Objective: This study was designed to observe the clinical sequelae of varicose veins after great saphenous vein (GSV)
ablation and to assess possible predictability of spontaneous varicose vein regression.
Methods: Patients with symptomatic varicose veins secondary to GSV insufficiency treated with radiofrequency ablation
(RFA)were enrolled in the study. Up to five of the largest varicose veins in each limbweremapped, sized, and documented
before RFA. No varicose vein was treated either at the time of RFA or within 6 months postoperatively. Varicose vein
status was recorded at follow-up visits.
Results: Fifty-four limbs in 45 patients were included. A total of 222 varicose veins were documented before RFA (4.1 
1.1 varicose veins per limb) with an average size of 11.4  3.7 mm. During the follow-up period, complete resolution of
visible varicose veins was seen in 13% of limbs after RFA alone, and 63 (28.4%) varicose veins spontaneously resolved. A
further 88.7% (141/159) of varicose veins decreased in size an average of 34.6% (4.3  3.4 mm). Preoperatively, 19.4%
of varicose veins were above the knee and 75.7% were below the knee. Complete varicose vein resolution was 41.9%
(18/43) above the knee and 25.6% (43/168) below the knee. For the above-knee varicose veins, 88.4% (38/43) were
located medially, and all the resolved ones (47.4%, 18/38) were medial varicose veins. Resolution rates of the 168
below-knee varicose veins were 30.6% (33/108) of medial, 23.1% (6/26) of anterior, 20.0% (3/15) of lateral, and 5.3%
(1/19) of posterior.
Conclusions: Great saphenous vein ablation resulted in subsequent resolution or regression of many lower-limb visible
varicose veins. With further study, the predictability of varicose vein regression may perhaps be increased, which can then
direct the treatment strategy to further leverage the advantages of minimally invasive endovenous procedures. ( J Vasc
Surg 2005;42:1145–9.)The traditional surgical treatment of symptomatic var-
icose veins arising from great saphenous vein (GSV) insuf-
ficiency has involved eliminating or reducing venous hyper-
tension in the GSV, accompanied by elimination of visible
varicosities by stab (avulsion) phlebectomy.1 In fact, the
complete extirpation of all visible varicosities is considered
by many to be an inviolable tenet of varicose vein surgery.2
Depending on the extensiveness of varicosities to be elim-
inated, the performance of multiple phlebectomies, usually
under general anesthesia, contributes to postoperative pain
and morbidity as well as prolonged recovery and delayed
return to normal activity.
The development of minimally invasive treatment of
the GSV with radiofrequency ablation (RFA) eliminated
part of the substantial surgical trauma involved in treating
these patients.3 In the hands of many surgeons, it is still
accompanied by multiple phlebectomies. The study re-
ported here arose out of a desire to minimize surgical
trauma in treating these patients, yet retain completeness
and durability of treatment.
A strategy was initiated to perform the GSV ablation
procedure without concomitant phlebectomy and to sub-
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Patients were seen within 3 days after the ablation proce-
dure, with the intent to perform sclerotherapy at that time.
After pursuing this strategy in approximately 30 patients, it
was observed at the postoperative visit that the varices in
many patients were substantially diminished from their
preoperative size. Occasionally, patients deferred sclero-
therapy for varying reasons, and on their subsequent re-
turn, further regression—and some disappearance—of
their varices was noted. Some of these patients had such
complete regression of their varicose veins after GSV abla-
tion alone that no further treatment of the varices was
pursued.
This study was undertaken in an attempt to address the
question of whether complete elimination of surface vari-
cosities is an obligatory accompaniment to treating the
GSV to achieve a satisfactory and durable symptomatic and
cosmetic outcome. The study represents a preliminary ob-
servational experience with a staged approach to treating
varicose veins that result from chronic superficial venous
hypertension. This approach involves treating the GSV
with radiofrequency ablation, with delayed treatment of
residual varicosities at 6 months.
METHODS
Starting in January 2003, 49 patients referred to this
office were enrolled. During the enrollment period, an
additional 25 potential study patients were treated with the
same strategy but not enrolled: 16 patients were not able to
comply with follow-up, 8 had hospital-based procedures
with no pre-operative vein measurements, and 1 patient
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follow-up. Of the 45 patients included, there was no selec-
tion bias based on clinical features. No patient with a
history of deep venous thrombosis or with abnormal deep
veins on ultrasound examination was included in the study.
All patients were advised of the treatment strategy and
protocol for the study, as well as standard treatment op-
tions, including multiple phlebectomies. Signed informed
consent was obtained for all patients.
All patients underwent a duplex ultrasound diagnostic
study that used a 10-MHz probe in an office setting. The
standard examination included an assessment for patency
and incompetence throughout the length of the great and
lesser saphenous veins, with patients reclining at 60°. When
results were questionable, the patients were re-examined
while standing. Perforators were sought at standard ana-
tomic locations as well as in relation to the presence of
otherwise unexplained varicosities. The deep veins were
also assessed, above, at, and below the saphenofemoral and
saphenopopliteal junctions.
Patients included in the study underwent successful
RFA of the GSV of one or both legs. Ablation failed in three
limbs in three patients who underwent bilateral treatment.
These three limbs were excluded from the study. The
extent of ablation extended from the saphenofemoral junc-
tion to the lowest point of reflux in the GSV, but not below
the upper calf.
The RFA procedure was performed under local and
tumescent anesthesia. Most patients were treated in the
office, and an oral sedative (5 mg diazepam) was taken
preoperatively. Those treated in an outpatient surgery cen-
ter setting received intravenous sedation. No patient re-
ceived a prescription for postoperative analgesia. All pa-
tients were seen 1 to 3 days postoperatively, and
postoperative follow-up at 2 and 6 months was completed.
Preoperatively, and at each postoperative visit, symp-
toms were assessed and recorded. CEAP clinical classifica-
tion was also determined. For each limb, the five largest
visible varicosities were identified for measurement at their
maximum diameters with the patient standing. Only varices
linked to the GSV were included. Those varices linked to
the lesser saphenous vein or incompetent perforator veins
were also managed within the staged strategy, but not
included in the study.
The clinical end point of the study was the change in
size of the varicose veins in response to saphenous ablation
alone. An electrocardiogram caliper and a millimeter scale
were used to determine the external diameter of the vein on
the skin. These measurements were recorded on a clinical
follow-up form. At the end of the 6-month period, patients
were given the option of sclerotherapy treatment of any
remaining varices, if needed. No patients requested, or
were treated with, phlebectomy. All treatment was done on
an ambulatory basis without interruption of daily activities,
other than for the time taken for treatment and the fol-
low-up sessions themselves.RESULTS
The 54 limbs of the 45 patients included in this report
underwent successful ablation of the GSV. The preopera-
tive CEAP distribution is shown in the Table. In the 54
limbs, 222 varicose veins were documented before RFA.
An average of 4.1  1.1 varicose veins, with an average
diameter of 11.4  3.7 mm, were documented per limb.
Four patients with five treated limbs never returned after
their 72-hour postoperative check-up, and 10 patients with
10 treated limbs did not return after the 2-month evalua-
tion. Thirty-one patients with 39 treated limbs completed
the 6-month study. Two of the patients who did not
complete the follow-up protocol moved and could not be
contacted. The other patients were contacted but declined
further follow-up, reporting satisfaction with their present
status.
The following results reflect measurements obtained at
each patient’s last visit during the study period. During the
follow-up period, 28.4% (n 63) of varicose veins sponta-
neously resolved, 4.5% were resolved at 2 months, and
another 23.9% had resolved by 6 months. Overall, com-
plete varicose vein resolution was seen in 13.0% of limbs
after RFA alone. Among 159 varicose veins that did not
resolve, 141 (88.7%) decreased in size, on an average of
34.6% (4.3  3.4 mm)(P  .05, paired t test). Ten (6.3%)
varicose veins did not change in size, and four (2.5%)
varicose veins increased in size by an average of 18.6% (1.3
 0.5 mm).
Varicose vein distribution before treatment is shown in
Fig 1. Preoperatively, 19.4% and 5.0% of varicose veins
were either above the knee or at the knee area, respectively,
and 75.7% were below the knee. As illustrated in Fig 2,
complete varicose vein resolution was 41.9% (18/43) for
above-knee locations, 18.2% (2/11) at the knee area, and
25.6% (43/168) for varicose veins documented below the
knee.
For the varicose veins located above the knee, 88.4%
(38/43) were located medially, and all the resolved ones
were medial varicose veins (18/38, 47.4%). For the 168
below-knee varicose veins, 64.3% were medial, 15.5% ante-
rior, 11.3% posterior, and 8.9% lateral. Resolution of be-
low-knee varicose veins was observed in 30.6% (33/108) of
medial locations, 23.1% (6/26) of anterior locations, and
20.0% (3/15) of laterally located varicose veins. Of the 22
varicose veins located posteriorly above or below the knee,
only one resolved spontaneously during the follow-up pe-
Table 1. Pre-operative CEAP clinical class distribution of
the 54 limbs studied
Maximum CEAP
clinical class Number of limbs Per cent of total (%)
2 29 53.7
3 4 7.4
4 20 37.0
5 1 1.9riod.
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some varicose veins decreased to a size of 6 mm—or in
four instances, thrombosed—and required no further cos-
metic procedure. Of the 159 unresolved varices, 98 were
assessed at 6 months. Of these, 47 had regressed to6mm
in diameter and generally required no further treatment
(Fig 3).
After the 6-month study period, of the 39 limbs of 31
Fig 1. Medial view of the lower limb depicts the preoperative
anatomic distribution of visible varicose veins. AK, Above knee
region; BK, below knee region.
Fig 2. Medial view of the lower limb shows the anatomic distri-
bution of varicose vein (VV) resolution. AK, Above knee region;
BK, below knee region.patients that completed the 6-month protocol, 16 limbs(41.0%) had no further treatment after RFA. Twelve limbs
(30.1%) underwent ultrasound-guided sclerotherapy of in-
competent tributaries of the GSV associated with persistent
varices. Three limbs (7.7%) underwent sclerotherapy for
surface varices. Eight limbs (20.1%) had both ultrasound-
guided and surface sclerotherapy.
During the study period, no new varices or recurrences
of regressed varices were observed. As noted, three limbs
failed ablation during the study period and were excluded
from the analysis, since the object was to assess the effect of
the varices when the underlying source of venous hyperten-
sion was eliminated.
No serious complications occurred in the study group.
Mild cases of superficial phlebitis in the untreated varices
have been observed in this practice. Because of this, a
compression stocking is prescribed to be worn for a week
after GSV ablation. No superficial phlebitis occurred in this
study group, however.
A review of the charts of those 25 patients not included
in the study, though not containing objective verification of
varicose vein regression, revealed relatively similar events in
further treatment. Thirty-six limbs were treated, of which 6
limbs (16.7%) had no further treatment after GSV ablation,
15 limbs (41.7%) underwent subsequent ultrasound-
guided sclerotherapy for incompetent tributaries, and 13
limbs (36.1%) had sclerotherapy of surface varices. Two
limbs (5.6%) underwent both ultrasound-guided sclero-
therapy and sclerotherapy of surface varices. The higher
rate of subsequent interventions compared with the study
group reflected the desire to proceed to treatment of per-
sistent varices sooner rather than following a deferment
period. Consequently, with less time allowed for regres-
sion, more varices were visible for treatment.
In a phone survey of the study group in January 2005,
which represented 12 to 24 months of follow-up, 36 pa-
tients with 46 treated limbs were contacted. Compared
with their preoperative status, 30 reported absence of
symptoms, and six reported improvement. With regard to
visible varices before surgery, 16 reported absence of vari-
ces, and 20 reported improvement. None reported new
symptoms or new varicosities. There was 100% satisfaction
with the treatment strategy.
DISCUSSION
Historically, the complete extirpation of visible varicose
veins has been a fundamental tenet in the optimal treatment
of varicose veins arising fromGSV insufficiency. In a review
of the history of varicose vein surgery in the United States,
no prior study was identified in which the GSV alone was
treated and phlebectomies deferred. In reports by Hom-
ans4 and Mayo5 at the beginning of the 20th century, the
need for complete removal of visible varicosities was en-
couraged to prevent recurrence. This dogma was repeated
throughout the remainder of the last 100 years. It was, and
is, believed that complete removal of the surface varicosities
interrupts incompetent tributaries and reduces recurrence
rates. Despite technologic innovations and the ensuing
improvements in diagnosis and treatment, this tenet has
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study.
In the United States, emphasis was directed to treating
primarily the GSV. Homans4 is credited with first pursuing
this treatment goal with high ligation of the GSV along
with complete division of proximal tributaries.6 Eventually,
perfection of GSV stripping was described by Myers1 and
Lofgren.7 de Takats8 staged treatment with high ligation of
the GSV followed by sclerotherapy, and recorded the phe-
nomenon of regression of varices between treatments, but
never reported the consequences of leaving the surface
varices untreated.
In Britain, Fegan9 and Hobbs10 later described treat-
ment that focused on sclerotherapy techniques for ablation
of incompetent perforator veins. Interestingly, they both
noted regression of varicosities after ablation of underlying
incompetent perforator vein sources of venous hyperten-
sion,9,11 and Fegan even asserted that the peripheral vari-
cosities could recover venous wall tone and valvular com-
petence.9 He cited the frequent regression in the
puerperium of varicosities arising during pregnancy as an
example of this event. However, despite Fegan’s assertion
and regardless of the approach taken to eliminate underly-
ing sources of venous hypertension, the complete extirpa-
tion of visible varicosities has generally been forcefully
Fig 3. Study patient No 16 before (left photo) and 6 mo
additional interventions for treatment of the visible var
medial upper calf.maintained.2,12The observations reported here suggest that an ap-
proach focusing on eradication of sources of venous hyper-
tension may decrease the necessity of treating surface vari-
cosities. Suggest is the operative word here, for longer
follow-up and greater numbers of patients will be needed to
determine what place, if any, this strategy will ultimately
have in the treatment of varicose veins. This approach
provides the opportunity of savings in both time and cost in
the treatment of surface varicosities. The attendant pain,
disability, and cosmetic consequences of surgical phlebec-
tomy are also avoided while satisfactory cosmetic and symp-
tomatic outcomes are still achieved.
A surface varicose vein may represent a first-order trib-
utary from the GSV, or perhaps a second, third, or higher
order. The resolution or persistence of a surface varix after
ablation of the GSV may reflect this relationship. It is
interesting to note that most of the varicosities were medi-
ally located, especially in the above-knee region. In above-
knee varicose veins, 41.9% resolved spontaneously after
GSV ablation, which may suggest their direct relationship
with the GSV. All of the resolved above-knee varicose veins
were medially located. Posterior varicose veins were less
prone to resolve spontaneously, whether the location was
above or below the knee.
The persistence of varicosities often reflected an incom-
after (right photo) radiofrequency ablation, without any
veins. Note the resolution of veins in the anterior andnths
icosepetent tributary of the GSV. Treating these persistent trib-
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directly treating the surface varices, usually resulted in
further regression of surface varices and presumably helped
prevent recurrence. These additional treatments are nearly
painless, take little time, and allow continuation of normal
activity. The ultimate place and timing of these additional
treatments will require further specific study.
It must be remembered that data were collected for the
five largest varices on a given limb. Regression of smaller
varices, though not documented, seemed to be more com-
plete. In some instances, a previous varix could still be
appreciated as a barely visible or palpable dilation of 3 to 6
mm, having become cosmetically irrelevant to the patient.
Because symptomatic resolution was so excellent with the
ablation procedure alone, many patients turned down cos-
metic sclerotherapy for barely noticeable residual varices.
These untreated varices are, of course, the center of future
evaluation in these patients. Durability of varicose vein
regression, affirmed in our relatively early follow-up, awaits
future reports.
The current study was designed to challenge conven-
tional treatment strategies. Further follow-up of this study
group is planned and will be reported. Many questions still
need to be answered in future studies, such as whether
aggressive treatment of incompetent tributaries and perfo-
rators after saphenous vein ablation will result in greater
and more durable regression of varicose veins, and how we
can reliably predict which varices will or will not regress.
This observational study had certain methodologic
weaknesses; however, even with its weaknesses, the results
are felt to be compelling enough to warrant notice and
further study. These preliminary data suggest the need for a
larger randomized study that would be designed to verify
the current findings. Though patient numbers are relatively
small, if regression reliably and durably occurs, then it
should be observable in even a few patients.
Only the five largest varices of each limb were docu-
mented. The caliper technique was, admittedly, fairly sim-
plistic, and it did not reflect the complete extent of varicose
vein involvement of a given limb. In retrospect, a method
such as grading by photograph, perhaps accompanied by
computer-assisted image analysis, might give more accurate
information. Ultrasound measurements would be helpful
in demonstrating the long-term fate of veins that regress
beyond visual discernment.
Even with these limitations, though, regression was
demonstrated with very high statistical significance. The
failure in patient compliance with completing the study
protocol perhaps reflects our general patient population.The phone survey results are important even though
they are not objective and their validity can be questioned.
Symptom eradication and good cosmetic outcome are the
primary goals of these patients. If at 12 to 24 months these
goals are still fulfilled, this validates treatment durability to
some degree. Objective follow-up is necessary, however,
and these patients will be recalled in the future for docu-
mentation of their outcomes.
CONCLUSION
This study represents a first attempt to provide evidence
for a deferred strategy for varicose vein treatment. If proven
durable, the advantage of this strategy is obvious. Bruising,
hematoma, infection, and other wound-related morbidities
associated with phlebectomy are eliminated as well as atten-
dant pain. The need for general anesthesia and a formal
operating room setting are eliminated. Normal activity is
essentially uninterrupted. These benefits, along with our
documented regression rate, might encourage a revision of
current practice strategies if long-term recurrence parallels
or improves upon historical standards.
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